CLINICAL_TRIALS
trial_result
· 2019-11-19
Clinical Trial Update: Switch to Maraviroc + Integrase Inhibitor [Phase 3]
Summary
Phase 3 clinical trial evaluating switching to maraviroc combined with an integrase inhibitor for HIV; trial status completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: HIV | Phase 3 | Status: COMPLETED | Results posted: 2019-11-19